Express Pharma - Express Pharma

Event in Hyderabad from September 26 to 28, 2012 to see participation from 60 overseas buyers

Board of directors recommends dividend of 0.25 paisa per share

If approved, this could be the first pharmaceutical therapy to treat patients with vitreomacular adhesion

The 20-member delegation will also attend Arogya 2012

To set up a scientist exchange programme between India and Denmark

To yield actionable insights and more effective personalised treatments

It is a new option for both first and second-line treatment

Taro will become a privately held company, will be wholly owned by affiliates of Sun Pharma

This was experienced by patients who take cholesterol-lowering drugs

Plant will support future growth in the region